Early State Lung Cancer

Advances in Lung Cancer Evaluation
and Management

Patient with Early Stage Lung
Cancer and Severe Emphysema:
Balancing the Treatment Options

Print this Content

 

Release Date:  October 17, 2011
Expiration Date: October 17, 2013

 

How to Obtain AMA PRA
Category 1 Credit™

  1. Complete the CME case-based lesson.
  2. Login to your account.
  3. Complete the registration / evaluation form.
  4. Print your personalized CME certificate.

Technical Requirements

  

Estimated Time of Completion: 30 minutes

Description

The case-based lesson will provide a clinically based overview of current issues in the multidisciplinary management of patients with lung cancer, with an emphasis on the impact of comorbidities on the selection of treatment.

Learning Objectives

  1. Discuss the current standards for lung cancer screening, diagnosis, and staging.
  2. Compare and contrast the efficacy and safety of treatment options for early and late-stage lung cancer, especially in patients with significant comorbidities.
  3. Debate the treatment options for both obstructive lung disease and lung cancer from surgical and medical viewpoints.

Target Audience

This activity is directed to medical oncologists, radiation oncologists, pulmonologists, thoracic surgeons, internists, and nurses.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Activity Directors

Peter Mazzone, MD
Department of Pulmonary, Allergy
   and Critical Care Medicine
Cleveland Clinic
Cleveland, OH

Nathan Pennell, MD
Department of Solid Tumor Oncology
Cleveland Clinic
Cleveland, OH

Faculty

Peter Mazzone, MD
Department of Pulmonary, Allergy
   and Critical Care Medicine
Cleveland Clinic
Cleveland, OH

Sudish Murthy, MD, PhD
Department of Cardiothoracic Surgery
Cleveland Clinic
Cleveland, OH

Nathan Pennell, MD
Department of Solid Tumor Oncology
Cleveland Clinic
Cleveland, OH

 

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship that, in the context of their presentation, could be perceived as a potential conflict of interest:

Peter Mazzone, MD

Boehringer Ingelheim:

 Membership on advisory committee or review panels
 
Sudish Murthy, MD, PhD

Hood Laboratories:

 Intellectual property rights (royalties or patent sales), inventor share, new mentor, consulting
 
Nathan Pennell, MD

Boehringer Ingelheim:

 Membership on advisory committee or review panels

The Cleveland Clinic Foundation Center for Continuing Education acknowledges
educational grants for partial support of this activity from:

Pfizer
Genentech
Merck

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education,
Respiratory Institute, and Taussig Cancer Institute.

CME Disclaimer